Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction
1Cardiac Care, Saint Vincents Hospital and Medical Center, 153 West 11th Street, Cronin 5-553, New York, NY 10011, USA. jambrose@saintvincentsnyc.org
Insights
Recent advances in acute coronary syndromes (ACS) management highlight the role of antithrombotic therapy and percutaneous coronary intervention. Risk-factor modification is crucial for preventing future events, with a future focus on primary prevention strategies.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Significant progress in understanding acute coronary syndromes (ACS) over the past two decades.
- Recognition of thrombus formation's critical role in ACS pathophysiology since the 1980s.
Purpose of the Study:
- To review the evolution of ACS management.
- To highlight key therapeutic advancements and future directions in ACS care.
Main Methods:
- Review of randomized studies and therapeutic modalities in ACS management.
- Analysis of the impact of antithrombotic therapy, percutaneous coronary intervention, and risk-factor modification.
Main Results:
- Antithrombotic therapy demonstrated efficacy in reducing myocardial infarction and death.
- Percutaneous coronary intervention, glycoprotein IIb/IIIa receptor antagonists, and coronary stents have improved patient outcomes.
- Risk-factor modification is essential for secondary prevention.
Conclusions:
- ACS management has been revolutionized by advancements in antithrombotic therapy and interventional cardiology.
- Future research and clinical efforts should prioritize primary prevention of cardiovascular disease.
Abstract:
In the last 20 years there have been enormous advances in our understanding of the acute coronary syndromes and how to manage patients presenting with them. In the 1980s, we began to understand the importance of thrombus formation was in the pathophysiology of acute coronary syndromes. Randomized studies also showed that appropriate antithrombotic therapy reduced the subsequent occurrence of myocardial infarction and death. In the 1990s, other therapeutic modalities and particularly percutaneous coronary intervention have come to the forefront as effective therapy in these syndromes. The glycoprotein IIb/IIIa receptor antagonists along with coronary stent implantation have proved extremely beneficial in short- and long-term management. We also have learned the importance of risk-factor modification in preventing subsequent events. In the future, greater efforts will focus on primary prevention.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:27Angina II: Classification
01:29Angina III: Clinical Manifestations and Assessment
01:20Angina V: Nursing Management